Navigation Links
CPhI Pharma Evolution to Address Practical Approaches to Process Analytical Technology in Interactive Interview with PAT Expert
Date:8/14/2013

NEW YORK, Aug. 14, 2013 /PRNewswire/ -- On Thursday, August 15, at 10:00 a.m. ET, CPhI Pharma Evolution's Editor-in-Chief, Agnes Shanley, will interview NIR spectroscopist and PAT expert Emil Ciurczak on practical approaches to Process Analytical Technology (PAT) in a live video chat. Since the FDA introduced the term in 2004, PAT has generated some confusion and misunderstanding among professionals in the pharmaceutical industry. Emil Ciurczak will address common myths and misconceptions, and share insights into how PAT can be implemented and used to improve efficiency and reduce quality assurance and control costs at any pharmaceutical facility.

Ciurczak was one of the first to apply PAT concepts, widely used in other industries such as chemicals and petrochemicals, and semiconductor manufacturing, to drug manufacturing and quality operations. He has worked in the pharmaceutical industry for over four decades. In 1983, he introduced NIR spectroscopy to pharmaceutical applications, and is generally credited as one of the first to use process analytical technologies in drug manufacturing and development. His research has focused on pharmaceutical applications of NIR, and he has published more than four dozen articles in refereed journals, over 150 magazine columns, and presented nearly 200 technical papers. Ciurczak is a regular blogger on PharmaEvolution.com.

For more information and to participate in the live video chat, click here: http://www.pharmaevolution.com/video-stream.asp?section_id=3043&doc_id=560780

Next week, on Thursday, August 22, at 10:00 a.m. ET, CPhI Pharma Evolution will host a video chat on Question-Based Review (QbR) for Generics with FDA expert. For more information, click here:

SOURCE CPhI Pharma Evolution
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. aTyr Pharma Awarded Two Patents from USPTO to Support Development of New Therapeutics Based on Physiocrine Biology
2. Ampio Pharmaceuticals, Inc. Announces Positive Results for Ampion in Osteoarthritis of the Knee Clinical Trial
3. aTyr Pharma Expands Executive Leadership Team to Support Development of New Therapeutics Based on Physiocrine Biology
4. Savient Pharmaceuticals Reports Second Quarter 2013 Financial Results
5. 200 Pharma Customers to Attend ChemOutsourcing September 17-19, 2013, NJ, USA
6. Simcere Pharmaceutical Group Reports Preliminary Unaudited Second Quarter 2013 Results
7. Robbins Arroyo LLP Is Investigating the Directors and Officers of Navidea Biopharmaceuticals, Inc.
8. Avanir Pharmaceuticals Announces Diabetes Co-Promotion Agreement with Merck
9. AcelRx Pharmaceuticals Reports Second Quarter 2013 Financial Results
10. PipelineRx Announces Telepharmacy Contract with GNYHA Services
11. Emdeon Continues Focus on Patient-Centered Healthcare Solutions; Renews Chain Drug Consortium Contract for Multiple Pharmacy Solutions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... , Aug. 28, 2015 ... has announced the addition of the "Investigation ... to their offering. Developed by AstraZeneca ... is an important drug for the treatment of ... 2000, quetiapine was listed in the Catalogue of ...
(Date:8/28/2015)... , Aug. 28, 2015  IP Shakti, LLC, today announced ... Logo - ... "Our new corporate identity signifies our transformation into a ... predictive analytics platform for patent claim validity." ... of the proprietary AIA Shield™ platform, the Company commenced a ...
(Date:8/28/2015)... 2015 , Joint research by Prof. ... Biostar , Published in ,Stem Cells Translational Medicine, ... through multiple IV administration of Adipose-derived MSC , ... found , Commercialization within 5 years expected ... that adult mesenchymal stem cells (MSCs) may extend healthy ...
Breaking Medicine Technology:China Quetiapine Market Investigation Report 2010-2019 2IP Shakti, LLC Changes Company Name to Prediqtus, LLC 2Korean Researchers Find the Possibility that Adult Mesenchymal Stem Cells (MSCs) May Extend Lifespan 2
... to New Prevention and Treatment Strategies--, PHILADELPHIA, Aug. ... main cause of the inherited version,of the childhood cancer ... play a significant role in high-risk forms of,non-inherited neuroblastoma, ... discovery enables us to offer the first genetic tests ...
... CLL, NHL and CLL Retreatment and Japanese Development Studies ... ... has,announced plans to begin four studies of ofatumumab in chronic lymphocytic,leukemia and ... four studies of,ofatumumab in chronic lymphocytic leukemia (CLL) and follicular,non-Hodgkin,s lymphoma (NHL) ...
Cached Medicine Technology:Gene That Causes Childhood Cancer Neuroblastoma Is Found 2Gene That Causes Childhood Cancer Neuroblastoma Is Found 3Gene That Causes Childhood Cancer Neuroblastoma Is Found 4Genmab Announces Upcoming Ofatumumab Studies 2Genmab Announces Upcoming Ofatumumab Studies 3Genmab Announces Upcoming Ofatumumab Studies 4
(Date:8/28/2015)... ... August 29, 2015 , ... Rio Salado College ... and the student experience as part of the EDUCAUSE - Next Generation Learning Challenges ... , This is the third Breakthrough Models Incubator hosted by EDUCAUSE and ...
(Date:8/28/2015)... , ... August 28, 2015 , ... ... Malaria Day at the Zoo to celebrate children helping children, a thank you ... congregations throughout West Ohio have contributed to the United Methodist initiative to end ...
(Date:8/28/2015)... ... ... With the goal of furthering music education programs in schools, the “Music ... Fairgrounds in Mendon, IL on May 30th, 2015. Backed once again by Best Drug ... underfunded school districts of Mendon and its neighboring town of Quincy, IL. Best Drug ...
(Date:8/28/2015)... ... August 28, 2015 , ... As reported by Medical Daily on August ... for results that last for two years, the longest of any cellulite reduction system ... looking for a long-lasting, effective solution for their cellulite, according to Dr. Robert Weiss, ...
(Date:8/28/2015)... ... August 28, 2015 , ... Loved ones of a person ... with chemical dependency, may be able to find some hope in the latest ... center for addiction located in Western Michigan. Focusing on several different aspects of ...
Breaking Medicine News(10 mins):Health News:Rio Salado College Joins 9 Educational Leaders to Reinvent Higher Learning 2Health News:Rio Salado College Joins 9 Educational Leaders to Reinvent Higher Learning 3Health News:Rio Salado College Joins 9 Educational Leaders to Reinvent Higher Learning 4Health News:Saturday’s United Methodist Event at Columbus Zoo Celebrates Imagine No Malaria 2Health News:Saturday’s United Methodist Event at Columbus Zoo Celebrates Imagine No Malaria 3Health News:Best Drug Rehabilitation Interviews Country-Rock Duo Highway Run at the 2015 "Music With A Mission" Benefit Concert 2Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 2Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 3Health News:Best Drug Rehabilitation Releases New Video Outlining Patients' Personal Recovery Stories 2Health News:Best Drug Rehabilitation Releases New Video Outlining Patients' Personal Recovery Stories 3
... LigoCyte Pharmaceuticals, Inc. announced today that its ... and related gastrointestinal illness collectively known as acute ... "the stomach flu" is one of the most ... and diarrhea afflicting 21 million Americans annually and ...
... -- Hispanic women have a 20 percent greater risk ... according to a new study. Biological differences in ... suggested. "This difference may be associated with a ... Baumgartner, an epidemiology professor at the School of Public ...
... By Mary Brophy Marcus HealthDay Reporter , WEDNESDAY, ... the outer layer of the brain and work its way ... upends long-held beliefs about the nervous system disease. The ... is diagnosed and treated, appear to solidify a theory that,s ...
... and the identification of sensitive biomarkers for early detection and/or ... New work published in the Dec. 7 issue of the ... the development of blood-based DNA markers for ovarian cancer. ... of Southern California in Los Angeles, found that a DNA ...
... Gardner HealthDay Reporter , WEDNESDAY, Dec. 7 ... appears to boost survival in women with certain types ... These preliminary findings regarding the bone-building drug zoledronic acid ... their tumors. The studies are slated for presentation at ...
... By Steven Reinberg HealthDay Reporter , ... are screened for and diagnosed with low-risk prostate cancer, ... National Institutes of Health panel concluded that research on ... prostate cancer is discovered, many men opt for surgery ...
Cached Medicine News:Health News:NEJM publishes study showing LigoCyte's norovirus vaccine demonstrates protection against illness 2Health News:NEJM publishes study showing LigoCyte's norovirus vaccine demonstrates protection against illness 3Health News:NEJM publishes study showing LigoCyte's norovirus vaccine demonstrates protection against illness 4Health News:Hispanic Women More Likely to Die of Breast Cancer 2Health News:MS May Take a Different Pathway Than Previously Thought 2Health News:MS May Take a Different Pathway Than Previously Thought 3Health News:Bone Drugs May Also Battle Breast Cancer, Researchers Say 2Health News:Active Surveillance May Benefit Men With Low-Risk Prostate Cancer 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: